PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

2010334 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 376, Issue 9749, pp. 1329-1337

Field-Weighted Citation Impact: 33.67